NCT06793735 · RECRUITING

Effectiveness of TeleVR App in Cognitive Decline and MCI Patients

This trial tests whether a virtual reality app used at home via smartphone or tablet — guided remotely by a therapist — improves cognition and social skills better than traditional paper-based exercises. Participants have Subjective Cognitive Decline or Mild Cognitive Impairment. Researchers also track brain activity, eye movements, and walking patterns. It is a Phase NA trial, meaning it is comparing two rehabilitation approaches rather than testing a new drug — no regulatory approval process is involved.

Inclusion criteria

  • Subjects diagnosed with MCI (AD and PD) according to the criteria of the National Institute on Aging-Alzheimer's Association (NIA-AA, Albert et al., 2011)
  • Subjects diagnosed with SCD according to diagnostic criteria proposed in research settings (Molinuevo et al., 2017)
  • All enrolled subjects must be aged between 40 and 80 years and have at least 5 years of education

Exclusion criteria

  • Presence of psychiatric disorders (major depression, psychosis, anxiety disorders)
  • Presence of severe dementia
  • History of cerebral ischemia
  • Contraindications to brain MRI: pregnant women, pacemakers, non-latest-generation metal joint prostheses, electrodes, neurostimulators, or prostheses that may interfere with magnetic fields, unless there is a written statement of suitability from the specialist who performed the intervention

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2026-04-03

View full record on ClinicalTrials.gov

All APOE4 clinical trials